IP Library Granted Patent US 9,765,395
Granted Patent B2
US 9,765,395 · App. 14/684,283 · Granted Sep 19, 2017

System and method for DNA sequencing and blood chemistry analysis

Inventor: Brett Goldsmith (San Diego, CA)
Assignee: Nanomedical Diagnostics, Inc.
C12Q1/6874G01N27/4145
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,765,395
App. No.
14/684,283
Granted
Sep 19, 2017
Kind
B2
Abstract

A DNA sequencing and blood chemistry analysis device is provided including one or more sensor chips and one or more sample wells, wherein each sample well is configured to form a seal with one of the sensors. The one or more sensor chips may comprise Graphene transistors, and each transistor having an associated sequencing probe. The sensor chips interact with a biological sample introduced into the sample well, wherein changes in the current, transconductance, and resistance of the Graphene transistors are indicative of a DNA binding process. Based on the associated sequencing probes, the DNA sequence present in a biological sample can be identified.

Claims (9)

1. A system for biological sample analysis comprising:

a biological sample sensor comprising a plurality of transistors, wherein at least one transistor comprises a scattering site;

at least one transistor comprises sp 2 hybridized Carbon in the form of Graphene and each scattering site comprises sp 3 hybridized Carbon, the sp 3 hybridized Carbon being covalently bonded to a sequencing probe, such that if the sequencing probe detects a complimentary DNA sequence while voltage is applied to the transistor, the electrical properties of the transistor will change;

a sample well having a bottom portion, wherein the sample well is in fluidic communication with the biological sample sensor; and

a computing module, wherein the computing module is configured to identify the DNA sequence based on the change in electrical properties of the at least one transistor.

2. The system of claim 1 , wherein the at least one transistor comprises a source lead, a gate lead, and a drain lead, and the source lead, the gate lead, and the drain lead each electrically couple to an external connector, the external connector supplies a voltage across the drain-source lead and a bias across the gate-source lead, and couples to an electrical properties measuring device.

3. The system of claim 1 , wherein the electrical properties measuring device is an amp-meter, a voltmeter, or a computer.

4. The system of claim 1 , wherein the bottom portion of the sample well forms an aperture and the aperture contacts and forms a liquid-tight seal with the biological sample sensor, such that when the biological sample is introduced to the sample well, the biological sample contacts a top surface of the biological sample sensor.

5. The system of claim 1 , wherein the biological sample is a suspension of a DNA sample.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Jun 27, 2023
From: BROADOAK FUND III, LLC
To: CARDEA BIO, INC.
Reel/Frame 064143/0489 →
CHANGE OF NAME Recorded Feb 10, 2023
From: NANOMEDICAL DIAGNOSTICS, INC.
To: CARDEA BIO, INC.
Reel/Frame 062703/0305 →
SECURITY INTEREST Recorded Apr 23, 2018
From: NANOMEDICAL DIAGNOSTICS, INC.
To: BROADOAK FUND III, LLC
Reel/Frame 045607/0282 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 10, 2015
From: GOLDSMITH, BRETT
To: NANOMEDICAL DIAGNOSTICS, INC.
Reel/Frame 035386/0035 →
Continuity (2)
Continuation In Part 14263954 · Apr 28, 2014
Related Publication 20150307936A1 · Oct 29, 2015